Yoshinobu Seki (Seki Yoshinobu)

Publication Activity (10 Years)

Years Active: 2016-2024
Publications (10 Years): 12

Top Topics

Venous Thromboembolism

Clinical Practice

Prognostic Factors

Top Venues

International journal of hematology

JMIR research protocols

Journal of thrombosis and haemostasis : JTH

International journal of laboratory hematology

This page only lists publications with an associated author ORCID identifier.

Publications

Yoshinobu Seki
Clinical guidelines for prevention and treatment of CAT in Japan and other countries. International journal of hematology 119 (5) (2024)
Yoshinobu Seki
Clinical guidelines for prevention and treatment of CAT in Japan and other countries. International journal of hematology 119 (5) (2024)
Yoshinobu Seki
Clinical guidelines for prevention and treatment of CAT in Japan and other countries. International journal of hematology 119 (5) (2024)
Yoshinobu Seki
Clinical guidelines for prevention and treatment of CAT in Japan and other countries. International journal of hematology (2024)
Yoshinobu Seki
Clinical guidelines for prevention and treatment of CAT in Japan and other countries. International journal of hematology 119 (5) (2024)
Yoshinobu Seki, Yoshiyuki Ogawa, Takahide Kikuchi, Emiko Sakaida, Yuki Mizuta, Tadayuki Kitagawa, Kazuhiko Takemura, Yasuo Miyaguchi, Keiji Nogami, Tadashi Matsushita
Efficacy and safety of recombinant porcine factor VIII in Japanese patients with acquired hemophilia A. International journal of hematology (2024)
Yuki Itagaki, Mineji Hayakawa, Yuki Takahashi, Yuichiro Sakamoto, Shigeki Kushimoto, Yutaka Eguchi, Yoshinobu Seki, Kohji Okamoto
Treatments for Trauma-Induced Coagulopathy: Protocol for a Systematic Review and Meta-Analysis. JMIR research protocols 12 (2023)
Masayuki Kubo, Kazuya Sakai, Masaki Hayakawa, Hirokazu Kashiwagi, Hideo Yagi, Yoshinobu Seki, Atsushi Hasegawa, Haruyuki Tanaka, Itsuto Amano, Yoshiaki Tomiyama, Masanori Matsumoto
Increased cleavage of von Willebrand factor by ADAMTS13 may contribute strongly to acquired von Willebrand syndrome development in patients with essential thrombocythemia. Journal of thrombosis and haemostasis : JTH 20 (7) (2022)
Yoshinobu Seki, Goichi Honda, Noriaki Kawano, Toshimasa Uchiyama, Kazuo Kawasugi, Seiji Madoiwa, Naoki Takezako, Ikezoe Takayuki, Hideo Wada
Clinical Features of Disseminated Intravascular Coagulation According to the French-American-British Classification in Patients With Acute Leukemia and Thrombomodulin Alfa Treatment-A Cohort Study Using a Postmarketing Surveillance Database. Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis 27 (2022)
Seiji Madoiwa, Goichi Honda, Noriaki Kawano, Toshimasa Uchiyama, Kazuo Kawasugi, Naoki Takezako, Kei Suzuki, Yoshinobu Seki, Takayuki Ikezoe, Kohji Okamoto, Hideo Wada
An evaluation of the Japanese Society on Thrombosis and Hemostasis criteria for disseminated intravascular coagulation as a predictor of prognosis in patients with infection. International journal of laboratory hematology 43 (6) (2021)
Yoshinobu Seki, Ouki Nagano, Ryo Koda, Shinichi Morita, Go Hasegawa
Pathological findings suggesting vascular endothelial damage in multiple organs in chronic myelogenous leukemia patients on long-term tyrosine kinase inhibitor therapy. International journal of hematology 112 (4) (2020)
Yoshinobu Seki, Kunihiko Wakaki
Pathological findings in a case of bone marrow carcinosis due to gastric cancer complicated by disseminated intravascular coagulation and thrombotic microangiopathy. International journal of hematology 104 (4) (2016)